Sahajanand Medical Technologies IPO GMP

Sahajanand Medical Technologies IPO is a Mainboard book-built issue comprising an Offer for Sale (OFS) of equity shares by existing shareholders. The company operates in the medical technology sector, manufacturing cardiovascular and vascular intervention

Today (23 October 2026)
₹17
Est. listing price₹361
Est. listing gain4.94%

Sahajanand Medical Technologies IPO GMP Today

Day-wise grey market premium. Est. listing = price cap (₹344) + GMP.

⚠GMP is unofficial and highly volatile. The Top Stock Broker does not deal in or facilitate grey-market trading.
GMP DateGMP (₹)Sub2 (₹)Kostak (₹)Est. Listing (₹)Est. Gain
23 October 2026 ₹17 ₹500 — ₹361 +4.9%
22 October 2026 ₹17 ₹500 — ₹361 +4.9%
21 October 2026 ₹21 ₹800 — ₹365 +6.1%
20 October 2026 ₹24 ₹500 — ₹368 +7%
19 October 2026 ₹24 ₹500 — ₹368 +7%
18 October 2026 ₹28 ₹500 — ₹372 +8.1%
17 October 2026 ₹15 ₹1,100 — ₹359 +4.4%
16 October 2026 ₹35 ₹1,400 — ₹379 +10.2%
15 October 2026 ₹43 ₹1,300 — ₹387 +12.5%
14 October 2026 ₹41 ₹1,200 — ₹385 +11.9%
13 October 2026 ₹41 ₹1,100 — ₹385 +11.9%
12 October 2026 ₹35 ₹1,300 — ₹379 +10.2%
11 October 2026 ₹40 — — ₹384 +11.6%

GMP → Listing Price Calculator

Enter a GMP to estimate listing price, gain and profit per lot. A math estimate only.

Estimated listing price—
Estimated listing gain—
Investment per lot—
Est. profit per lot—

Sahajanand Medical Technologies IPO Details

IPO Open
Oct 15, 2026
IPO Close
Oct 19, 2026
Price Band
₹327 – ₹344
Lot Size
43 shares
Issue Size
₹475.48 Crore (1,38,22,116 shares)
Face Value
₹1
Allotment Date
Oct 21, 2026
Listing Date
Oct 23, 2026

See the full Sahajanand Medical Technologies IPO details & review →

What is Sahajanand Medical Technologies IPO GMP?

Sahajanand Medical Technologies IPO GMP refers to the unofficial premium at which IPO shares are reportedly traded in the grey market before listing. It indicates market sentiment but is not an official stock exchange price and does not guarantee listing gains.

What was the final GMP of Sahajanand Medical Technologies IPO?

The last reported GMP was approximately ₹17 per share on 23 October 2026, the listing date. Against the issue price of ₹344, this implied an estimated listing price of ₹361.

What was the estimated listing price based on GMP?

Based on the final reported GMP of ₹17 and the issue price of ₹344, the estimated listing price was ₹361 per share, implying a potential gain of approximately 4.94%. The actual listing price differed from this estimate.

Does GMP guarantee listing gains?

No. GMP does not guarantee listing gains or a positive listing. Actual share prices depend on investor demand, market conditions, valuation and buying and selling activity on the exchanges. A positive GMP can still be followed by lower-than-expected listing performance.

Where can investors check Sahajanand Medical Technologies IPO allotment status?

The IPO allotment was finalised on 21 October 2026. Investors can check their allotment status through the official registrar, MUFG Intime India, or the relevant stock exchange application-status pages. Shares were scheduled to be credited to successful applicants’ Demat accounts on 22 October 2026.

Frequently Asked Questions

Sahajanand Medical Technologies IPO GMP is the unofficial premium or discount at which its shares are reportedly traded in the grey market before listing. It is not an official exchange quotation.

The final reported GMP was approximately ₹17 per share on the listing date. Against the issue price of ₹344, this implied an estimated listing price of ₹361, or a potential gain of 4.94%.

The estimated listing price is calculated by adding the reported GMP to the upper end of the IPO price band. With an upper issue price of ₹344 and a reported GMP of ₹40, the indicative listing price is ₹384 per share. This estimate may change before listing and does not guarantee the actual market price.

No. A positive GMP suggests favourable sentiment in the unofficial grey market, but it does not guarantee a listing premium. The actual listing price depends on investor demand, subscription levels, broader market conditions and trading activity on the listing day. Shares can still list below the issue price despite a positive GMP.

Sahajanand Medical Technologies IPO shares were listed on the BSE and NSE on 23 October 2026. The shares opened at ₹371.15 on the NSE against the issue price of ₹344, recording a listing gain of ₹27.15 per share, or approximately 7.89%.